In a joint statement, Friends of Cancer Research and the American Society of Clinical Oncology affirmed the need for broadening clinical trial eligibility criteria to expand patient access to ...

If randomised controlled trials can be successfully emulated using real-world data (RWD), confidence in the validity of RWD for estimating treatment effects for questions that have not been assessed ...

Michael Hofman’s presentation at PSMA and Beyond 2025 highlighted the evolving role of the PRIMARY score in prostate cancer diagnosis. The PRIMARY study demonstrated that combining PSMA PET with MRI ...

Purpose: Existing T3 subclassifications for upper tract urothelial cancer (UTUC) are limited by heterogeneity and a primary focus on renal pelvis tumors. Our study aimed to propose a novel pT3 ...

To investigate physical and psychological sexual dysfunction (SD) in prostate cancer (PCa) patients, according to disease stage and treatment modality. Participants diagnosed with PCa completed an ...

Objectives: The aim of this work was to review the available evidence on transperineal focal laser ablation (FLA) for patients with localized PCa, focusing on both functional and oncological outcomes.

Despite diagnostic and therapeutic advances, renal cell carcinoma (RCC) metastasis remains difficult to eliminate. Copper metabolism MURR1 domain-containing 5 (COMMD5), a protein involved in tubular ...

Aggressive variant and androgen receptor (AR)-independent castration resistant prostate cancers (CRPC) represent the most significant diagnostic and therapeutic challenges in prostate cancer. This ...

Background/Objectives: Conventional transurethral resection of bladder tumor (TURBT) for non-muscle invasive bladder cancer (NMIBC) is usually performed in a piecemeal manner, leading to difficulties ...

Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET geographical coverage and supply chain Reno, Nevada ...

Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials in Urology Additional updates from across CG Oncology’s ...

Prostate cancer is a significant health issue worldwide, but methods to screen for and diagnose this disease have significant inherent limitations. Some efforts to address these limitations have ...